Readthrough drugs work by promoting the cellular machinery to bypass or "read through" these premature stop codons. This process enables the ribosome to continue translation, potentially restoring the production of full-length, functional proteins. The ability of readthrough drugs to restore protein function is especially crucial for genes that play a role in inhibiting tumor growth and progression.
